A modified bleb needling procedure performed in the operating room can reduce or maintain a target IOP for patients with uncontrolled IOP, according to a study.Needling of a scarred trabeculectomy bleb can prevent patients from undergoing further exten…
What if we are wrong about the cause of dry eye disease?It is not very likely, I know, but what if we are? What if inflammation is not the primary event in the pathophysiology of DED, but is rather no higher than second on the cascade? For some 15 year…
The ReCLAIM phase 1 study evaluating the use of elamipretide for intermediate age-related macular degeneration has been initiated, according to a press release from Stealth BioTherapeutics.The open-label study will evaluate elamipretide’s safety and tolerability through 12 weeks of treatment with daily subcutaneous injections, the release said. Patients will be age 55 years or older and have at least one eye with intermediate AMD, as well as either drusen on the retina without geographic atrophy or geographic atrophy with an unaffected central fovea.
A 17-year-old boy was noted to have an abnormal appearance of the optic disc in his left eye. What is the most likely diagnosis? Medscape Ophthalmology
TearLab reported a net loss of $4 million, or $0.07 per share, in the third quarter compared with a net loss of $8.1 million, or $0.24 per share, in the third quarter of 2015.Quarterly net revenues were up 9% from $6.6 million in 2015 to $7.2 million, …
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Ophthalmic Lasers Market by Product Type, Application, & End User – Global Forecast to 2021” report to their offering. The ophthalmic lasers market is projected to reach USD 1.2 billion by 2021 from USD 970.2 million in 2016, at a CAGR of 5.1%. Increasing prevalence of ophthalmic disorders, increasing prevalence of chronic disorders, rising geriatric population, increasing regulatory approvals, and increasing i